• 出版社/出版日：Mordor Intelligence / 2018年3月
|Single User（1名様用）||￥463,250 (USD4,250)||▷ お問い合わせ|
|Team User（7名様用）||￥490,500 (USD4,500)||▷ お問い合わせ|
|Corporate User||￥953,750 (USD8,750)||▷ お問い合わせ|
The global protein fractionation market is expected to reach USD 17.56 million by 2023, witnessing a CAGR of 6.3% during 2018-2023 (forecast period). The protein fractionation market is highly fragmented; the fractionation methods are continuously evolving and there is a continuous demand for better and cost-efficient techniques. Moreover, proteins are the key areas of focus for the food, pharmaceutical and diagnostics industries. The consumption of proteins varies with the type of sources such as plant or animal. Plant protein, being a sustainable source of protein with high digestibility, has a growing market.
As the lifestyle diseases are growing, people are becoming more aware of their health which can boost fitness, sports, and weight management industries. There is a growing market for protein application due to its muscle building property and nutritional value. Proteins are used in food industry mainly into sports nutrition products, infant formula, meat extenders, dietary supplement, nutraceuticals and various processed food. The various forms of proteins used by food and pharma industries are protein isolate, concentrate and textured proteins. The increased market for specific forms of proteins has risen the demand for protein fractionation.
This Ion Exchange technology holds a major share in the market. Ion exchange chromatography separates compounds according to the nature and degree of their ionic charge. Ion exchange chromatography is a powerful tool for use in protein purification. This method is frequently used in both analytical and preparative separations. Chromatographic columns can either be prepared to facilitate both anion exchange and cation exchange. The ion exchange method is one of the most frequently used techniques for protein purification owing to its high protein binding capacity, its effectiveness in removing unwanted impurities in the sample and relative ease by which it can be performed. The ion exchange method also has widespread applicability, high resolving power, high capacity and high simplicity and controllability, thereby making it a preferable method over other chromatographic methods.
North America accounted for the highest share of the protein fractionation market, followed by Europe and Asia-Pacific. The growth in the North America can be attributed to the developed pharmaceutical and biotechnology R&D infrastructure, technological advancements in the proteomics field and presence of a high number of protein purification and isolation market players. However, the Asia-Pacific region represents the fastest growing market for the protein purification and isolation during the forecast period.
MAJOR PLAYERS: AFFYMETRIX, INC., AGILENT TECHNOLOGIES, INC., BIO-RAD LABORATORIES, INC., BRUKER CORPORATION, CLONTECH, DANAHER CORPORATION, GE HEALTHCARE, LUMINEX CORPORATION, MERCK KGAA, NEW ENGLAND BIOLABS, PERKINELMER, INC., QIAGEN, THERMO FISHER SCIENTIFIC, INC. and WATERS CORPORATION, amongst others.
Reasons to Purchase this Report
• Analyzing outlook of the market with the recent trends and Porter’s five forces analysis.
• Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period.
• Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects.
• Country-level analysis, integrating the demand and supply forces that are influencing the growth of the market.
• Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years.
• Comprehensive company profiles, covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet (in excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.レポート目次
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Market Definition
2. Research Approach & Methodology
2.2 Research Designs
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering and Econometric Modelling
2.4.4 Expert Validation
3. Market Overview
3.1 Market Trends
4. Market Dynamics
4.1.1 High R&D Expenditure in Protein Synthesis
4.1.2 Increasing Demand for Biotechnology in the Food Industry and Protein Titres
4.1.3 Growing Application in Proteins and Specialty Food Ingredients Industries
4.2.1 Non Cooperative Regulatory Environment
4.2.2 High Cost Of Tools, Instruments and Maintenance
4.2.3 Challenge in Protein Recovery and Improving the Speed of Protein Purification
4.3.1 Biomarker Identification
4.3.2 New Avenues of Protein Applications
5. Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitute Products and Services
5.5 Degree of Competition
6. Market Segmentation
6.1 By Fractionation Methodology
6.1.1 Fractionation by Solubility
6.1.2 Fractionation by Cellular Location
6.1.3 Fractionation by Charge
6.1.4 Fractionation by PI
6.1.5 Fractionation by Size
6.2 By Chromatographic Technology
6.2.1 Affinity Chromatography
6.2.2 Ion Exchange
6.2.3 Hydrophobic Interaction
6.2.4 Size Exclusion
6.3 By Geogrpahy
6.3.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
6.3.4 South America
184.108.40.206 South Africa
7. Competitive Landscape
7.1 Strategies Adopted by Players
7.2 Most Active Companies in the Past Five Years
7.3 Market Share Analysis
8. Company Profiles
8.1 Affymetrix, Inc.
8.2 Agilent Technologies, Inc.
8.3 Bio-Rad Laboratories, Inc.
8.4 Bruker Corporation
8.6 Danaher Corporation
8.7 GE Healthcare
8.8 Luminex Corporation
8.9 Merck KGaA
8.10 New England Biolabs
8.11 Perkinelmer, Inc.
8.13 Thermo Fisher Scientific, Inc.
8.14 Waters Corporation